Related references
Note: Only part of the references are listed.Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Vanessa Monteil et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
An Infectious cDNA Clone of SARS-CoV-2
Xuping Xie et al.
CELL HOST & MICROBE (2020)
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Shuai Xia et al.
CELL RESEARCH (2020)
Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?
Muthukrishnan Eaaswarkhanth et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
Katharine H. D. Crawford et al.
VIRUSES-BASEL (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
Changhai Lei et al.
NATURE COMMUNICATIONS (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
Ahmed O. Hassan et al.
CELL (2020)
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Fabian Schmidt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures
Nikolai Eroshenko et al.
NATURE BIOTECHNOLOGY (2020)
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
Emma S. Winkler et al.
NATURE IMMUNOLOGY (2020)
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Ludovico Cantuti-Castelvetri et al.
SCIENCE (2020)
Ig-like ACE2 protein therapeutics: A revival in development during the COVID-19 pandemic
Kewen Qian et al.
MABS (2020)
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
Jianhui Nie et al.
EMERGING MICROBES & INFECTIONS (2020)
Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activation
Pan Liu et al.
KIDNEY INTERNATIONAL (2018)
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome
Akram Khan et al.
CRITICAL CARE (2017)
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging
Roy L. Maute et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Receptor Recognition Mechanisms of Coronaviruses: a Decade of Structural Studies
Fang Li
JOURNAL OF VIROLOGY (2015)
Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
Manuel Haschke et al.
CLINICAL PHARMACOKINETICS (2013)
Enhanced Recognition and Neutralization of HIV-1 by Antibody-Derived CCR5-Mimetic Peptide Variants
Jessica J. Chiang et al.
JOURNAL OF VIROLOGY (2012)
Quantification of Reverse Transcriptase Activity by Real-Time PCR as a Fast and Accurate Method for Titration of HIV, Lenti- and Retroviral Vectors
Jolien Vermeire et al.
PLOS ONE (2012)
Ready, Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion Competence
Taylor Heald-Sargent et al.
VIRUSES-BASEL (2012)
Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
Sandrine Belouzard et al.
VIRUSES-BASEL (2012)
A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry
Ana Shulla et al.
JOURNAL OF VIROLOGY (2011)
Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
Ilona Glowacka et al.
JOURNAL OF VIROLOGY (2011)
Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2 Prevention of Angiotensin II-Dependent Hypertension
Jan Wysocki et al.
HYPERTENSION (2010)
Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2
Shutoku Matsuyama et al.
JOURNAL OF VIROLOGY (2010)
Trilogy of ACE2: A peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters
Keiji Kuba et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Anti-retroviral activity of TRIM5 alpha
Emi E. Nakayama et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells
Eric Campeau et al.
PLOS ONE (2009)
Soluble CD4 and CD4-Mimetic Compounds Inhibit HIV-1 Infection by Induction of a Short-Lived Activated State
Hillel Haim et al.
PLOS PATHOGENS (2009)
Implication of TRIMalpha and TRIMCyp in interferon-induced anti-retroviral restriction activities
Laetitia Carthagena et al.
RETROVIROLOGY (2008)
Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus
Paul B. McCray et al.
JOURNAL OF VIROLOGY (2007)
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
F Li et al.
SCIENCE (2005)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis
JL Guy et al.
FEBS JOURNAL (2005)
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
M Stremlau et al.
NATURE (2004)
Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein
T Giroglou et al.
JOURNAL OF VIROLOGY (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
A novel coronavirus associated with severe acute respiratory syndrome
TG Ksiazek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Angiotensin-I-converting enzyme and its relatives
JF Riordan
GENOME BIOLOGY (2003)
Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme
D Harmer et al.
FEBS LETTERS (2002)
Share Paper
